<VariationArchive RecordType="classified" VariationID="12899" VariationName="NC_000002.12:g.(?_165985812)_(166002754_166009718)del" VariationType="Deletion" Accession="VCV000012899" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2020-10-20" MostRecentSubmission="2020-10-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="27938" VariationID="12899">
      <GeneList>
        <Gene Symbol="LOC102724058" FullName="uncharacterized LOC102724058" GeneID="102724058" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165957418" stop="166036400" display_start="165957418" display_stop="166036400" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="SCN1A" FullName="sodium voltage-gated channel alpha subunit 1" GeneID="6323" HGNC_ID="HGNC:10585" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165984641" stop="166149161" display_start="165984641" display_stop="166149161" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166845669" stop="167005641" display_start="166845669" display_stop="167005641" Strand="-" />
          </Location>
          <OMIM>182389</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN1A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000002.12:g.(?_165985812)_(166002754_166009718)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" innerStart="165985812" innerStop="166002754" outerStop="166009718" display_start="165985812" display_stop="166009718" variantLength="23907" />
      </Location>
      <OtherNameList>
        <Name>EX21-26DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.(?_165985812)_(166002754_166009718)del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.(?_165985812)_(166002754_166009718)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="182389.0018" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for allelic variant 182389.0018 from the annotation of SCN1A on GRCh38.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000002.12:g.(?_165985812)_(166002754_166009718)del AND Severe myoclonic epilepsy in infancy" Accession="RCV000032607" Version="27">
        <ClassifiedConditionList TraitSetID="1766">
          <ClassifiedCondition DB="MedGen" ID="C0751122">Severe myoclonic epilepsy in infancy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2006-09-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2006-09-26" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-10-20" MostRecentSubmission="2020-10-20">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17000989</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1766" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4140" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 6 (Dravet syndrome)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epilepsy, Myoclonic, Infantile, Severe</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 6A</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe myoclonic epilepsy in infancy</ElementValue>
                <XRef ID="219513" DB="GeneTests" />
                <XRef ID="Dravet+Syndrome/2332" DB="Genetic Alliance" />
                <XRef ID="230437002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dravet syndrome</ElementValue>
                <XRef ID="MONDO:0100135" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ICE-GTC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DEE6A</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EIEE6</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DRVT</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SMEI</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SME</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">SCN1A seizure disorders encompass a spectrum that ranges from simple febrile seizures and generalized epilepsy with febrile seizures plus (GEFS+) at the mild end to Dravet syndrome and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) at the severe end. Phenotypes with intractable seizures including Dravet syndrome are often associated with cognitive decline. Less commonly observed phenotypes include myoclonic astatic epilepsy (MAE), Lennox-Gastaut syndrome, infantile spasms, epilepsy with focal seizures, and vaccine-related encephalopathy and seizures. The phenotype of SCN1A seizure disorders can vary even within the same family.</Attribute>
                <XRef ID="NBK1318" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301494</ID>
                <ID Source="BookShelf">NBK1318</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_Dravet.pdf</URL>
                <CitationText>Orphanet, Dravet syndrome, 2008</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <Citation Type="Suggested Reading">
                <ID Source="PubMed">28880996</ID>
              </Citation>
              <XRef ID="33069" DB="Orphanet" />
              <XRef ID="C0751122" DB="MedGen" />
              <XRef ID="MONDO:0100135" DB="MONDO" />
              <XRef Type="MIM" ID="607208" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="93554" SubmissionDate="2020-10-09" DateLastUpdated="2020-10-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="182389.0018_DRAVET SYNDROME" title="SCN1A, EX21-26DEL_DRAVET SYNDROME" />
        <ClinVarAccession Accession="SCV000056361" DateUpdated="2020-10-20" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-09-26">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with Dravet syndrome (DRVT; 607208) manifest as severe myoclonic epilepsy of infancy (SMEI), Mulley et al. (2006) used multiplex ligation-dependent probe amplification (MLPA) to identify a de novo heterozygous deletion of exons 21 through 26 of the SCN1A gene. The phenotype was similar to SMEI patients with coding or splicing SCN1A mutations.</Attribute>
              <Citation>
                <ID Source="PubMed">17000989</ID>
              </Citation>
              <XRef DB="OMIM" ID="607208" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN1A" />
          </GeneList>
          <Name>SCN1A, EX21-26DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX21-26DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="182389.0018" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DRAVET SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="93554" TraitType="Disease" MappingType="Name" MappingValue="DRAVET SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0751122" Name="Severe myoclonic epilepsy in infancy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

